Pull to refresh
Logo
Daily Brief
Following Why Ranks Sign Up
Yilai Shu

Yilai Shu

Principal Investigator, Eye and ENT Hospital of Fudan University

Appears in 1 story

Notable Quotes

This marks the world's first effective clinical trial of gene therapy for hearing loss, with the largest number of cases and the first human trial using a dual AAV vector.

Stories

Gene therapy restores hearing in deaf patients

New Capabilities

Led first successful human gene therapy trial for hearing loss

Children born profoundly deaf can now hear their parents' voices. A single injection of gene therapy into the inner ear restored hearing in dozens of patients, moving genetic deafness from permanent disability to treatable condition. The effect is rapid—most patients recover hearing within weeks and retain it for at least two years.

Updated May 19